Histamine N-methyltransferase

Histamine N-methyltransferase (HNMT) is an enzyme that plays a crucial role in the metabolism of histamine in the human body. It is responsible for the methylation of histamine, converting it into N-methylhistamine, which is a less active form. This process is essential for regulating histamine levels and preventing excessive histamine activity, which can lead to various allergic and inflammatory responses.
Function[edit]
HNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to the imidazole ring of histamine, producing N-methylhistamine and S-adenosylhomocysteine (SAH). This reaction is a key step in the inactivation of histamine, particularly in tissues where the enzyme diamine oxidase (DAO) is not present or is less active.
Distribution[edit]
HNMT is widely distributed in various tissues throughout the body, including the liver, kidney, spleen, and central nervous system. Unlike DAO, which is primarily found in the gastrointestinal tract, HNMT is the main enzyme responsible for histamine degradation in the brain.
Genetic Variability[edit]
The gene encoding HNMT is located on chromosome 2q22.1. Genetic polymorphisms in the HNMT gene can affect the enzyme's activity and stability. One well-studied polymorphism is the Thr105Ile variant, which has been associated with altered enzyme activity and has implications for conditions such as allergic rhinitis, asthma, and atopic dermatitis.
Clinical Significance[edit]
Abnormal HNMT activity can lead to dysregulation of histamine levels, contributing to various medical conditions. Reduced HNMT activity has been linked to increased susceptibility to allergic diseases and certain neurological disorders. Conversely, increased HNMT activity may help protect against excessive histamine-related responses.
Research and Therapeutic Potential[edit]
Research into HNMT and its genetic variants continues to provide insights into the role of histamine in health and disease. Understanding the enzyme's function and regulation could lead to new therapeutic approaches for managing histamine-related conditions, including the development of HNMT inhibitors or enhancers.
See Also[edit]
References[edit]
External Links[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian